M63T (p.Met63Thr) variant of KRT4 (Keratin, type II cytoskeletal 4)
M63T (p.Met63Thr) in KRT4 (Keratin, type II cytoskeletal 4) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
M63T (p.Met63Thr) variant details
- p.Met63Thr
- NCI-TCGA Cosmic COSV9954
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available